16/06/2023
Some of our amazing team supporting Nuffield Department of Medicine University of Oxford
We are a University of Oxford specialist centre for the management and recruitment of participants t
16/06/2023
Some of our amazing team supporting Nuffield Department of Medicine University of Oxford
19/07/2022
Looking for a new challenge? We have a Clinical Trial Manager vacancy have a look at the details below
20/05/2022
Today is International !! Celebrate those taking part in research in Oxford! Over 100 years of research experience and support in one photo! 🎉
03/03/2022
A number of Oxford BRC-supported academics have been named National Institute of Health Research (NIHR) Senior Investigators in recognition of their outstanding leadership in research.
Three BRC-funded professors got the prestigious award for the first time:
• David Beard, Professor of Musculoskeletal and Surgical Science
• Julia Hippisley-Cox, Professor of Clinical Epidemiology and General Practice
• Najib Rahman, Professor of Respiratory Medicine
Three more were reappointed as Senior Investigators:
• Eleanor Barnes, Professor of Hepatology and Experimental Medicine
• Graham Ogg, Professor of Dermatology
• Paul Aveyard, Professor of Behavioural Medicine
Congratulations to all of them!
https://orlo.uk/l6AHN
25/05/2021
A study using cutting-edge hyperpolarised xenon MR imaging has identified persistent damage to the lungs of COVID-19 patients at least three months after they were discharged from hospital, and for some patients even longer.
This damage was not detected by routine CT scans and clinical tests, and the patients would consequently normally be told their lungs are normal.
The study’s Principal Investigator is Prof Fergus Gleeson, Professor of Radiology at the University of Oxford and Consultant Radiologist at OUH.
His team, who are supported by the NIHR Oxford BRC, has now begun testing patients who were not hospitalised with COVID-19 but who have been attending long COVID clinics.
â–¶ http://orlo.uk/fR3eQ
20/05/2021
More than 7,000 Oxfordshire COVID-19 study participants thanked - Oxford University Hospitals More than 7,000 Oxfordshire COVID-19 study participants thanked
23/04/2021
"Our collective strength throughout the COVID-19 pandemic has been in our shared sense of purpose which has enabled us to pull together during the darkest times."
Today sees the launch of 'Stories from the COVID-19 pandemic - ' - an e-Book which tells the story of our response to COVID-19, created with the generous support of our friends at Oxford Hospitals Charity.
You can read it here: http://orlo.uk/c6F10
It is also available via the article on the front page of our website, ouh.nhs.uk.
It gives us an opportunity to focus on our unique partnership with the University of Oxford and the groundbreaking COVID-19 research which has taken place in Oxford.
It also profiles some of our teams which are not always visible - as they work 'behind the front line' - and highlights the invaluable support of the wider community in Oxfordshire for NHS staff throughout the COVID-19 pandemic.
Thank you, all of you, for your support, and we hope you enjoy our e-Book.
16/03/2021
13/03/2021
ICYMI | A new home monitoring service has benefitted more than 160 extremely vulnerable patients with interstitial lung diseases (ILD).
Patients have been monitored from their own home, reducing the need to attend hospital and risk of catching
Dr Rachel Hoyles, Lead Interstitial Lung Diseases consultant, said: "Home spirometry allows patients to monitor their lung condition without leaving their home, which is especially important for a specialist ILD centre such as ours where patients travel from across Oxfordshire and the surrounding counties.
"The results which patients email to us allow our specialist team to detect any changes early, rapidly follow this up with video review and treatment if required. In its first few months, this service has already made a clear positive impact on patient care."
â–¶ http://orlo.uk/kqjn5
04/03/2021
PRINCIPLE Covid-19 treatments trial widens to under 50s and adds colchicine | University of Oxford From today, the UK’s national priority platform trial of Covid-19 treatments for recovery at home launches its investigation of the gout drug colchicine, and expands for the first time to include adults of any age.
08/01/2021
Our aim is to get patients home as soon as they are well enough as this frees up beds for the most seriously ill patients.
If you are a relative or carer of a patient ready to be discharged and are asked to help, please do what you can to support our staff.